PDT Partners’s CRH Medical Corporation CRHM Stock Holding History

PDT Partners’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,864	Closed	-$63K	–	488
2019 Q1	$63K	Hold	23,864	–	–	﹤0.01%	423
2018 Q4	$73K	Sell	23,864 -7,105	-23%	-$23.4K	﹤0.01%	452
2018 Q3	$123K	Buy	+30,969	New	+$114K	0.01%	456
2017 Q4	–	Sell	-50,162	Closed	-$130K	–	581
2017 Q3	$130K	Hold	50,162	–	–	﹤0.01%	504
2017 Q2	$285K	Buy	50,162 +32,013	+176%	+$208K	0.01%	458
2017 Q1	$148K	Buy	+18,149	New	+$126K	0.01%	449

Other funds holding CRHM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

SCM

Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PDT Partners's CRHM Position: Q2 2019 in Review

PDT Partners sold out of CRH Medical Corporation (CRHM) in Q2 2019, closing a stake of 23,864 shares — an estimated $63K sold.

PDT Partners first reported a position in CRHM in Q1 2017 and held it in 6 quarters. The position peaked at $285K in Q2 2017. 35 funds tracked by Wall St. Rank hold CRHM as of Q2 2019.

PDT Partners reported no remaining CRH Medical Corporation position as of Q2 2019 after selling out during the quarter.
PDT Partners sold 23,864 CRH Medical Corporation shares in Q2 2019, an estimated $63K.
PDT Partners first reported a position in CRH Medical Corporation in Q1 2017 and held it in 6 quarters.
PDT Partners's CRH Medical Corporation position peaked at $285K in Q2 2017.
35 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2019.

Based on PDT Partners's 13F filing for Q2 2019, filed 14 Aug 2019.